Capital and Coast District Health Board logo

FINCH 1

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

This study is currently recruiting participants.

Trial website: https://clinicaltrials.gov/ct2/show/NCT02889796?term=rheumatoid+arthritis+filgotinib&rank=4 

Trial purpose: The primary objective of this study is to evaluate the effects of filgotinib versus placebo in adults with active rheumatoid arthritis (RA) who have an inadequate response to methotrexate (MTX).

FINCH 3

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Trial website: https://clinicaltrials.gov/ct2/show/NCT02886728?term=rheumatoid+arthritis+filgotinib&rank=3 

Trial purpose: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination With Methotrexate (MTX) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy

Last updated 8 August 2017.